vduxwn.wiki • Professional Insights • Expert Commentary • Resource Center
vduxwn.wiki

Modern Style Guide,from

by HWM van Deutekom·2015·Cited by 104—We predicted thepeptide-bindingrepertoireof a large set ofHLAmolecules and used the overlap of thepeptide-bindingrepertoiresof each pair ofHLA

:between HLA repertoire

A
Alice Morgan

studies '' system performance and optimization while sharing regular updates via LinkedIn and Quora

Published on

Executive Summary

between HLA repertoire by HWM van Deutekom·2015·Cited by 104—We predicted thepeptide-bindingrepertoireof a large set ofHLAmolecules and used the overlap of thepeptide-bindingrepertoiresof each pair ofHLA

The intricate liaison between repertoire HLA and peptide is a fundamental aspect of the adaptive immune system, dictating how our bodies recognize and respond to threats. Human leukocyte antigen (HLA) molecules, also known as Human Leukocyte Antigen or HLA, are crucial cell-surface proteins responsible for presenting peptide fragments to T cells. This presentation is highly specific, with each HLA allele possessing a unique peptide-binding repertoire. Understanding this complex interaction is key to comprehending immune surveillance, vaccine development, and the mechanisms behind autoimmune diseases and transplant rejection.

The peptide-binding repertoire of an HLA molecule refers to the diverse collection of peptides that a specific HLA allele can bind and present. This repertoire is not random; it is largely determined by the structure of the HLA molecule's peptide-binding groove, particularly its "pockets." These pockets are shaped by the amino acid residues of the HLA molecule and dictate which peptide anchor residues can bind effectively. For instance, Human leukocyte antigen (HLA)-I molecules generally bind short peptides (8-10 amino acids), with specific anchor residues at defined positions, often at the C-terminus or at position 2. However, some studies indicate that peptides of >10 residues play a significant role in immune surveillance by T cells restricted by some HLA class I alleles.

The diversity of HLA alleles within a population leads to a vast array of peptide repertoires. This genetic polymorphism ensures that the immune system can recognize a wide range of pathogens. Research has shown that there can be significant overlap in the repertoires of peptides bound in vivo by different HLA allotypes. This means that even structurally different HLA molecules can present some of the same peptides. Studies have explored this phenomenon, investigating the peptide repertoires between HLA alleles and identifying similarities, such as the peptide repertoire of HLA-B*14:03 closely resembling that of HLA-B*27:05 at certain peptide positions. This overlap can be influenced by various factors, including the amino acid sequence motifs of the peptides.

The process of peptide loading onto HLA molecules is highly regulated. In the case of HLA class II molecules, the HLA-DM acts as a catalyst for peptide loading by facilitating the release of the invariant chain-derived fragment, CLIP, and stabilizing empty MHC molecules. Similarly, HLA-DM functions in antigen presentation by optimizing the selection of peptides for presentation. The efficiency and specificity of this loading process directly impact the peptide repertoire presented by each HLA molecule.

Research utilizing mass spectrometry has been instrumental in characterizing these peptide-HLA interactions. Each HLA allele is estimated to bind and present a substantial number of unique peptides, ranging from thousands to tens of thousands. These identified peptides are then presented to T cells, initiating an immune response. The Human leukocyte antigen (HLA) system plays a pivotal role in the immune response to viral infections, mediating the presentation of viral peptides to T cells.

Furthermore, variations in HLA molecules can lead to differences in their peptide-binding preferences. Each HLA variant has its own repertoire of presented peptides with a certain sequence motif, mainly defined by peptide anchor residues. This inherent selectivity means that some HLA alleles may be associated with narrower repertoires than others. For instance, it has been observed that HLA-B alleles are associated with significantly narrower repertoires than HLA-A alleles.

The study of peptide presentation by HLA molecules is critical for advancements in immunology and medicine. Understanding the peptide repertoire associated with specific HLA alleles can inform the design of more effective vaccines, as well as personalized therapies for cancer and autoimmune diseases. The liaison between repertoire HLA and peptide is a dynamic and complex interplay, essential for maintaining immune homeostasis and protecting the host from a constantly evolving array of threats. The ability to predict or characterize the peptide repertoire of a given HLA molecule is a significant area of ongoing research, promising further insights into the intricacies of the immune system.

Related Articles

Frequently Asked Questions

Here are the most common questions about .

Human leukocyte antigen(HLA) molecules present smallpeptideantigens to T cells, thereby allowing them to recognize pathogen-infected and cancer cells. A 
Closer Peptide Repertoire Similarity of HLA-B∗14:03 - PMC
by JG Abelin·2017·Cited by 728—EachHLAallele is estimated to bind and present ∼1,000–10,000 uniquepeptidesto T cells (Hunt et al., 1992, Rammensee et al., 1995, Vita et al 
by L Cobos-Figueroa·2025·Cited by 2—The B∗14:03peptide repertoiremost closely resembles that of B∗27:05 at the P1, P2, and P5peptidepositions but diverges at the C-terminus, 

Leave a Comment

Share your thoughts, feedback, or additional insights on this topic.

Explore More